Search clinical trials for: Liver tumour(s)

Total 81467 results

SynCore Biotechnology Co., Ltd.

No longer available

Long-Term Compassionate Use Study for Continued Administration of SCB01A-01

Malignant Solid Tumour
Maastricht Radiation Oncology

Completed

Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor (L19-IL2)

Solid Tumour

Netherlands
Nerviano Medical Sciences

Completed

Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors

Solid Tumour

United States
Kyowa Kirin Co., Ltd.

Terminated

Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

Solid Tumour

Singapore
GI Biome, Inc.

Recruiting

Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer

Cancer | Colorectal Cancer | Rectal Cancer | Solid Tumor | Sigmoid Colon Cancer | Rectosigmoid Junction Cancer

Korea, Republic of
AstraZeneca

Completed

A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

Solid Tumour

United States
Durham University
County Durham and Darlington NHS Foundation Trust

Suspended

Terahertz Metamaterials for Tumour Marker Concentration Identification

Malignant Tumour

United Kingdom
e-Therapeutics PLC

Completed

A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

Solid Tumour

United Kingdom
Institut Claudius Regaud
Merck Sharp & Dohme LLC

Terminated

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Malignant Solid Tumour

France
Xlumena, Inc.

Completed

AXIOS Stent & Delivery System Study

Pancreatic Pseudocyst(s)

United States, Spain
University Health Network, Toronto

Recruiting

Study of Biomarkers in Gynecological Cancers

Gynecologic Cancer

Canada
Estas Tıbbi Mamülleri Medikal
Klinar CRO

Recruiting

Clinical Evaluation of Moment Tumor Hip Replacement Products (KRIOS)

Primary and Secondary Bone Tumor in the Proximal Femur Region

Turkey
Royal Marsden NHS Foundation Trust

Recruiting

Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck (DART)

Head and Neck Cancer

United Kingdom
Walter and Eliza Hall Institute of Medical Research
Johns Hopkins University

Active, not recruiting

Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer

Ovarian Cancer

Australia, United States
Spanish Cooperative Group for the Treatment of...
Roche Pharma AG

Completed

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells (VISNU-1)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer (GECA)

Metastatic Pancreatic Cancer

Spain
Spanish Cooperative Group for the Treatment of...

Completed

Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques (ULTRA)

Stage IV Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer (AVAXEL)

Rectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...

Completed

Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours (MACRO-2)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Amgen

Completed

Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA) (SPECTRA)

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Merck Sharp & Dohme LLC

Terminated

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

Metastatic Colorectal Cancer

Spain
Washington University School of Medicine
Columbia University; Indiana University; Rakai Health Sciences Program; Reach the...

Active, not recruiting

Kyaterekera Project: A Combination Intervention Addressing Sexual Risk-Taking Behaviors Among Vulnerable Women in Uganda

Control arm_Bolstered Care | Treatment arm_HIVRR+S+FL | Treatment arm_HIVRR+S+FLM

Uganda
CCTU- Cancer Theme
Cambridge University Hospitals NHS Foundation Trust; University of Cambridge

Unknown

LUCID - LUng Cancer CIrculating Tumour Dna Study (LUCID)

Non Small Cell Lung Cancer

United Kingdom
Elina Brinck

Not yet recruiting

KetaMoHydBup: Pharmacokinetic Interaction of S-ketamine, Morphine, Hydromorphone and Buprenorphine (KetaMoHydBup)

The Effect of S-ketamine on Pharmacokinetics of Morphine, Hydromorphone, and Buprenorphine
Second Affiliated Hospital, School of Medicine,...
Sir Run Run Shaw Hospital; Zhejiang Provincial People's Hospital

Active, not recruiting

Construction and Validation of Risk Prediction Model for PICC Catheter Displacement

Cancer Patients With PICC

China
ImmunityBio, Inc.

Completed

Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid Tumors

Malignant Solid Tumour

United States
SCRI Development Innovations, LLC
Novartis

Completed

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

Malignant Solid Tumour

United States
Bio-Thera Solutions

Terminated

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

Advanced Solid Tumour

Australia
The University of Texas Health Science Center at...
Merck Sharp & Dohme LLC

Completed

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

Malignant Solid Tumour

United States
University of Pittsburgh
Bristol-Myers Squibb

Completed

Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies

Malignant Solid Tumour

United States
Otsuka Beijing Research Institute

Completed

Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors

Malignant Solid Tumour

Singapore
Jewish General Hospital

Unknown

Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients

Malignant Solid Tumour

Canada
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Nivestim™ in Treatment of Malignant Diseases

Solid Tumour | Malignant Haematological Tumour | Primary or Secondary Prophylactic Treatment

Germany
National Cheng-Kung University Hospital

Completed

Sigmoid Colon Organ Motion in Radiotherapy

Sigmoid Colon Cancer | Sigmoid Cancer

Taiwan
University Health Network, Toronto
U.S. Army Medical Research and Development Command; Princess Margaret Hospital...

Active, not recruiting

Transrectal Tumour Oxygen - US Army

Prostatic Neoplasms

Canada
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

Advanced Malignant Tumour
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors

Malignant Solid Tumour

China
Ipsen

Completed

BN80927 in Patients With Advanced Malignant Solid Tumors

Malignant Solid Tumour

France
ASLAN Pharmaceuticals

Completed

A Phase I Multiple Ascending Dose Study of ASLAN002 in Subjects With Advanced or Metastatic Solid Tumours

Malignant Solid Tumour
Boehringer Ingelheim

Completed

To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours

Malignant Solid Tumour

Germany
The Netherlands Cancer Institute
Pfizer

Unknown

Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors

Malignant Solid Tumour

Netherlands
University Hospital Heidelberg

Not yet recruiting

Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor (PAMSARC)

Synovial Sarcoma | Desmoplastic Small Round Cell Tumor

Germany
Spanish Cooperative Group for the Treatment of...

Completed

Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma (SEQUENCE)

Metastatic Pancreatic Adenocarcinoma

Spain
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer (SETICC)

Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Amgen

Completed

Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer (FRAIL)

Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Amgen

Completed

Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC

Metastatic Colorectal Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Sanofi; Hoffmann-La Roche

Completed

Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status

Gastric Cancer

Spain
Spanish Cooperative Group for the Treatment of...
Sanofi; Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma

Esophageal Carcinoma

Spain
Pere Planellas Giné

Completed

Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL) (CMELL)

Colorectal Cancer | Sigmoid Cancer

Spain
Chinese University of Hong Kong

Recruiting

The Global En Bloc Resection of Bladder Tumour Registry

Bladder Cancer

Hong Kong

3

Subscribe